2015-19159. Importer of Controlled Substances Registration: Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC registration as an importer of those controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    By notice dated April 14, 2015, and published in the Federal Register on April 22, 2015, 80 FR 22552, Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC, 3500 Dekalb Street, St. Louis, Missouri 63118 applied to be registered as an importer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007).

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the basic classes controlled substances:

    Controlled substanceSchedule
    Cathinone (1235)I
    Methcathinone (1237)I
    Mephedrone (4-Methyl-N-methylcathinone (1248)I
    N-Ethylamphetamine (1475)I
    Aminorex (1585)I
    Gamma Hydroxybutyric Acid (2010)I
    Methaqualone (2565)I
    Alpha-ethyltryptamine (7249)I
    Ibogaine (7260)I
    Lysergic acid diethylamide (7315)I
    Marihuana (7360)I
    Tetrahydrocannabinols (7370)I
    Mescaline (7381)I
    4-Bromo-2,5-dimethoxyamphetamine (7391)I
    4-Bromo-2,5-dimethoxyphenethylamine (7392)I
    4-Methyl-2,5-dimethoxyamphetamine (7395)I
    2,5-Dimethoxyamphetamine (7396)I
    3,4-Methylenedioxyamphetamine (7400)I
    N-Hydroxy-3,4-methylenedioxyamphetamine (7402)I
    3,4-Methylenedioxy-N-ethylamphetamine (7404)I
    3,4-Methylenedioxymethamphetamine (7405)I
    4-Methoxyamphetamine (7411)I
    Bufotenine (7433)I
    Diethyltryptamine (7434)I
    Dimethyltryptamine (7435)I
    Psilocybin (7437)I
    Psilocyn (7438)I
    1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)I
    N-Benzylpiperazine (7493)I
    MDPV (3,4-Methylenedioxypyrovalerone) (7535)I
    Heroin (9200)I
    Normorphine (9313)I
    Etonitazene (9624)I
    Amphetamine (1100)II
    Methamphetamine (1105)II
    Methylphenidate (1724)II
    Amobarbital (2125)II
    Pentobarbital (2270)II
    Secobarbital (2315)II
    Start Printed Page 46328
    Glutethimide (2550)II
    Nabilone (7379)II
    Phencyclidine (7471)II
    Cocaine (9041)II
    Codeine (9050)II
    Oxycodone (9143)II
    Hydromorphone (9150)II
    Diphenoxylate (9170)II
    Ecgonine (9180)II
    Ethylmorphine (9190)II
    Hydrocodone (9193)II
    Levorphanol (9220)II
    Meperidine (9230)II
    Methadone (9250)II
    Morphine (9300)II
    Thebaine (9333)II
    Opium, powdered (9639)II
    Levo-alphacetylmethadol (9648)II
    Oxymorphone (9652)II
    Fentanyl (9801)II

    The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis.

    In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes are authorized for this registration.

    Start Signature

    Dated: July 29, 2015.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2015-19159 Filed 8-3-15; 8:45 am]

    BILLING CODE P

Document Information

Published:
08/04/2015
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2015-19159
Pages:
46327-46328 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2015-19159.pdf